Delivery Order SPE2DB20D2104-SPE2DB23FS15N
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $2,329.53 by the Defense Logistics Agency (DLA) to provide NAFTIN 2% GEL 45GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a maximum potential value of $999,999,999.00 and a period of performance...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,211.25 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a completion date of January 12, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.94 firm-fixed-price delivery order is for the supply of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of September 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,057.46 firm-fixed-price contract is for the delivery of Naftifine HCL 2% gel, a topical antifungal medication, with a completion date of April 25, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $1,080.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 1% GEL 60GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $1,598.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NAFTIN 1% GEL 60GM, a pharmaceutical product, with a completion date of September 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,639.82 to supply Naftifine HCL 2% Gel in 60-gram quantities. This competitively awarded contract, with no set-aside designation, was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The delivery order employs firm...
- This federal contract award is for the delivery of NAFTIN 2% GEL 45GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations registered in the System for Award Management (SAM.gov). The contract, valued at $4,801.13, is a delivery order with a firm fixed price. It has an ultimate completion date of September 12, 2023. The contract is not...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.04 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel in 45-gram units. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NAFTIFINE HCL 2% CREAM 45GM. The $2,163.33 Firm Fixed Price contract has a completion date of September 22, 2021. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS15NDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 10, 2023. The contract is for the delivery of NAFTIN 2% GEL 45GM, with a ceiling value of $1,476.78 and a completion date of February 13, 2023. The contract is a Firm Fixed Price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/10/23 |